Search

Your search keyword '"Melanie Galla"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Melanie Galla" Remove constraint Author: "Melanie Galla"
67 results on '"Melanie Galla"'

Search Results

1. Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs

2. Protection from cisplatin-induced hearing loss with lentiviral vector-mediated ectopic expression of the anti-apoptotic protein BCL-XL

3. Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction

4. MCK2-mediated MCMV infection of macrophages and virus dissemination to the salivary gland depends on MHC class I molecules

5. Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells

6. Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance

7. Generation of an NFκB-Driven Alpharetroviral 'All-in-One' Vector Construct as a Potent Tool for CAR NK Cell Therapy

8. Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout

9. Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

10. CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo

11. Gammaretroviral Vectors: Biology, Technology and Application

12. Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase

13. Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

14. Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis.

15. MHC class Ia molecules facilitate MCK2-dependent MCMV infection of macrophages and virus dissemination to the salivary gland

16. Retroviral gene therapy in Germany with a view on previous experience and future perspectives

17. Design and Characterization of an 'All-in-One' Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines

18. Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout

19. Design and Characterization of an 'All-in-One' Lentiviral Vector System Combining Constitutive Anti-G

20. Targeted delivery of regulatory macrophages to lymph nodes interferes with T cell priming by preventing the formation of stable immune synapses

21. CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo

22. Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

23. Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

24. The Guanine-Nucleotide Exchange Factor Caldag Gefi Fine-Tunes Functional Properties of Regulatory T Cells

25. Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy

26. Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration

27. Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy

28. Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase

29. Hepatic T Cell Tolerance Induction in An Inflammatory Environment

30. In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity

31. Pseudotype-Independent Nonspecific Uptake of Gammaretroviral and Lentiviral Particles in Human Cells

32. Viral and Non-Viral Approaches for Transient Delivery of mRNA and Proteins

33. Development of Novel Efficient SIN Vectors with Improved Safety Features for Wiskott–Aldrich Syndrome Stem Cell Based Gene Therapy

34. Gammaretroviral Vectors: Biology, Technology and Application

35. Polyclonal fluctuation of lentiviral vector–transduced and expanded murine hematopoietic stem cells

36. Recombinase-Mediated Cassette Exchange (RMCE): Traditional Concepts and Current Challenges

37. Retroviral and Transposon-Based Tet-Regulated All-In-One Vectors with Reduced Background Expression and Improved Dynamic Range

38. CRISPR/Cas9 Genome Editing Using Gold-Nanoparticle-Mediated Laserporation

39. Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design

40. Protein transduction from retroviral Gag precursors

41. Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors

42. Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral Vectors

43. Viral and Synthetic RNA Vector Technologies and Applications

44. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors

45. Retrovirus Vectors: Toward the Plentivirus?

46. Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research

47. Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis

48. Cell and Virus Genetics at the Roots of Gene Therapy, Retrovirology, and Hematopoietic Stem Cell Biology: Wolfram Ostertag (1937–2010)

49. Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery

50. Operational tolerance in allotransplantation by use of regulatory T cells with a MHC-specific chimeric antigen receptor

Catalog

Books, media, physical & digital resources